News

Latest Industry Updates

From company milestones to industry breakthroughs, uncover the stories making waves and shaping the narrative in real time.

CluePoints Announced as Fierce Life Sciences Innovation Awards Finalist
RBQM leader secures finalist position in the Data Analytics/Business Intelligence category at prestigious...
Read
Continuous Review Needs Consolidated Evidence and Fewer Dashboards
Continuous data review calls for fewer dashboards and one body of consolidated evidence, built with RBQM...
Read
CluePoints Shortlisted for 2026 Scrip Awards for the Third Time in Eight Years
Clinical Trial Vanguard covers CluePoints’ 2026 Scrip Awards shortlisting and what it signals about data...
Read
The Unquantified Value of RBQM: Reduced Rework, Data Integrity, and Inspection Readiness
In this video interview, Sylviane de Viron of CluePoints and Abigail Dirks of Tufts CSDD discuss what...
Read
Why Time Savings Is the Largest Driver of RBQM's Financial Value
In this video interview, Sylviane de Viron of CluePoints and Abigail Dirks of Tufts CSDD explain why...
Read
Why Quantifying the Financial Value of RBQM Has Been So Hard- and What This Study Did Differently
In this video interview, Sylviane de Viron of CluePoints and Abigail Dirks of Tufts CSDD explain how...
Read
1 2 3 … 36
CluePoints Announced as Fierce Life Sciences Innovation Awards Finalist

RBQM leader secures finalist position in the Data Analytics/Business Intelligence category at prestigious awards. WAYNE, PA...

Continuous Review Needs Consolidated Evidence and Fewer Dashboards

Continuous data review calls for fewer dashboards and one body of consolidated evidence, built with RBQM...

Source: Contract Pharma

CluePoints Shortlisted for 2026 Scrip Awards for the Third Time in Eight Years

Clinical Trial Vanguard covers CluePoints’ 2026 Scrip Awards shortlisting and what it signals about data oversight...

Source: The Clinical Trial Vanguard

The Unquantified Value of RBQM: Reduced Rework, Data Integrity, and Inspection Readiness

In this video interview, Sylviane de Viron of CluePoints and Abigail Dirks of Tufts CSDD discuss...

Source: Tufts Center for the Study of Drug Development

Why Time Savings Is the Largest Driver of RBQM’s Financial Value

In this video interview, Sylviane de Viron of CluePoints and Abigail Dirks of Tufts CSDD explain...

Source: Applied Clinical Trials

Why Quantifying the Financial Value of RBQM Has Been So Hard- and What This Study Did Differently

In this video interview, Sylviane de Viron of CluePoints and Abigail Dirks of Tufts CSDD explain...

Source: Applied Clinical Trials

CluePoints Shortlisted for 2026 Scrip Awards Following 2023 and 2025 Wins

The two-time category winner secures finalist position in the Best Contract Research Organization (Specialist Providers) category....

Trial Complexity is the New Normal

Clinical trial complexity is now the norm: more endpoints, more procedures, narrower eligibility criteria, and more...

Source: pharmaphorum

CluePoints Launches Three AI-Led Clinical Data Review Capabilities, Co-Innovated with a Top 10 Pharmaceutical Company

Intelligent Query Detection, Medical & Safety Review and Intelligent Medical Coding are now generally available, extending...

Making the Financial Case for Risk-Based Quality Management in Clinical Research- Q&A

New peer-reviewed research puts hard numbers to the financial value of RBQM, showing ROI multiples up...

Source: The Association of Clinical Research Professionals

The CRA of the Future

Clinical research associates are evolving from compliance-focused manual monitors to data-enabled strategic site partners, but organizations...

Source: Applied Clinical Trials

Applying Risk-Based Oversight to Ensure Real-World Data Integrity

Clinical trials have undergone a period of immense change. Use of real-world data (RWD) is increasing....

Source: PharmaLive

CluePoints named as Finalist in 2025 ACDM Awards

The Company, along with its Research and Development Teams, were shortlisted for continuing its mission of...

CluePoints Appoints Richard Young as Chief Strategy Officer

CluePoints Appoints Richard Young as Chief Strategy Officer King of Prussia, PA – October 28th, 2024:...

CluePoints Wins Growth Award at BVA Private Equity Awards

King of Prussia, PA – October 23rd, 2024: CluePoints, provider of leading statistical and AI-driven software...

CluePoints Launches Medical & Safety Review (MSR) Software to Revolutionize Clinical Data Review

CluePoints furthers its commitment to delivering innovative solutions that enhance clinical trial efficiency with this latest...

CluePoints Continues ‘Turning Artificial Intelligence into Human Intelligence’ by Launching Two New Innovations

Site Profile & Oversight Tool (SPOT) and Intelligent Medical Coding (IMC) unveiled by RBQM innovator at...

CluePoints, a Leading Provider of AI-Driven Software Solutions for Clinical Data Review, Receives Significant Investment for Continued Growth from EQT

CluePoints is a cloud-based software platform for Risk-Based Quality Management (“RBQM”) and data quality oversight in...

CluePoints Brand Evolution Confirms Commitment to ‘Turning Artificial Intelligence into Human Intelligence’

KING OF PRUSSIA, Pa., — CluePoints, provider of leading statistical and AI-driven software solutions, today unveiled...

FDA And CluePoints Sign New 3 Year Cooperative Research And Development Agreement To Assess Data Quality Using Statistical Modelling And Machine Learning

King of Prussia, PA: CluePoints, providers of leading statistical and AI-driven software solutions and Food and...

CluePoints’ Site Profile & Oversight Tool (SPOT) shortlisted as finalist in 2024 Citeline Awards

King of Prussia, PA – March 25, 2024: CluePoints, providers of best-in-class statistical and AI-driven software...

Scope of Industry Risk-Based Quality Management (RBQM) Adoption Revealed

King of Prussia, PA: A comprehensive assessment of risk-based quality management (RBQM) adoption has revealed that...

CluePoints’ Audit Trail Review Project Wins Award for Innovation in the Management of Clinical Data Award

King of Prussia, PA – March 5, 2024: CluePoints, providers of best-in-class statistical and AI-driven software...

Game-Changing ‘Audit Trail Review’ Application Secures ACDM 2024 Awards Nomination for CluePoints

King of Prussia, PA – February 6, 2024: CluePoints, providers of best-in-class statistical and AI-driven software...

The Risk-Based Data Management (RBDM) Revolution

The clinical trials landscape is evolving with more data, increased investment in personalized medicines and a...

Source: Clinical Research News

Leveraging Machine Learning and Deep Learning for Natural Language Processing in Clinical Data Management

Nicolas Huet, CluePoints Machine Learning Manager, discusses developments in the use of machine learning and deep...

Source: Pharmaceutical Outsourcing

The Future of RBQM Adoption

In the fifth and final part of this video interview series, Ken Getz, executive director and...

Source: Applied Clinical Trials

Potential Pitfalls Without RBQM Adoption

In part 4 of this video interview series, Ken Getz, executive director and research professor, Tufts...

Source: Applied Clinical Trials

Increasing Comfortability With Adopting Risk-Based Approaches

In part 3 of this video interview series, Ken Getz, executive director and research professor, Tufts...

Source: Applied Clinical Trials

Ken Getz of Tufts CSDD and Steve Young of CluePoints Discuss Stand Out Results from Recent RBQM Study

In part 2 of this video interview series, Ken Getz, executive director and research professor, Tufts...

Source: Applied Clinical Trials

Ken Getz of Tufts CSDD Discusses RBQM Study Conducted with CluePoints and PwC

In part 1 of this video interview series with Ken Getz, executive director and research professor,...

Source: Applied Clinical Trials

Clinical Research 2.0 Must Embrace Change

We are at a tipping point in the adoption of Clinical Research 2.0. The evolution of...

Source: PM360

SCOPE 2024: Steve Young of CluePoints Discusses RBQM and Key Risk Indicators

In an interview with ACT editor Andy Studna at SCOPE, Young, Chief Science Officer, CluePoints discusses...

Source: Applied Clinical Trials

Does Central Statistical Monitoring Improve Data Quality? An Analysis of 1,111 Sites in 159 Clinical Trials

Central monitoring aims at improving the quality of clinical research by pro-actively identifying risks and remediating...

Source: Springer Link

Trendspotting: What’s Coming for Clinical Trials and Research in 2024

We spoke with leaders and experts in the Clinical Research community about their predictions for 2024.

...

Source: Clinical Research News

Ukraine War’s Impact on Clinical Research: Evidence from Key Risk Indicators

Key risk indicators (KRIs) are commonly used as an important component of central monitoring to enable...

Source: Applied Clinical Trials